Literature DB >> 26643549

Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.

Bieneke Janssen1, Danielle J Vugts2, Uta Funke3, Ger T Molenaar3, Perry S Kruijer4, Bart N M van Berckel2, Adriaan A Lammertsma2, Albert D Windhorst5.   

Abstract

Neuroinflammation is thought to play a pivotal role in many diseases affecting the brain, including Alzheimer's disease, multiple sclerosis and stroke. Neuroinflammation is characterised predominantly by microglial activation, which can be visualised using positron emission tomography (PET). Traditionally, translocator protein 18kDa (TSPO) is the target for imaging of neuroinflammation using PET. In this review, recent preclinical and clinical research using PET in Alzheimer's disease, multiple sclerosis and stroke is summarised. In addition, new molecular targets for imaging of neuroinflammation, such as monoamine oxidases, adenosine receptors and cannabinoid receptor type 2, are discussed. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Microglia; Multiple sclerosis; Neuroinflammation; Positron emission tomography; Stroke

Mesh:

Substances:

Year:  2015        PMID: 26643549     DOI: 10.1016/j.bbadis.2015.11.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

Review 1.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

Review 2.  Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back.

Authors:  Elena S Haight; Thomas E Forman; Stephanie A Cordonnier; Michelle L James; Vivianne L Tawfik
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

Review 3.  New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.

Authors:  Laura Best; Christine Ghadery; Nicola Pavese; Yen Foung Tai; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2019-04-02       Impact factor: 5.081

4.  Letter to the Editor re: Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration.

Authors:  Tina Notter; Urs Meyer
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

Review 5.  Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.

Authors:  T Notter; J M Coughlin; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-12-05       Impact factor: 15.992

6.  Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.

Authors:  T Notter; J M Coughlin; T Gschwind; U Weber-Stadlbauer; Y Wang; M Kassiou; A C Vernon; D Benke; M G Pomper; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

7.  Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.

Authors:  Rawaha Ahmad; Andrey Postnov; Guy Bormans; Jan Versijpt; Mathieu Vandenbulcke; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-03       Impact factor: 9.236

8.  Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Authors:  Zhen Fan; Melanie Dani; Grazia D Femminella; Melanie Wood; Valeria Calsolaro; Mattia Veronese; Federico Turkheimer; Steve Gentleman; David J Brooks; Rainer Hinz; Paul Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

Review 9.  Sifting through the surfeit of neuroinflammation tracers.

Authors:  Paul Cumming; Bjorn Burgher; Omkar Patkar; Michael Breakspear; Neil Vasdev; Paul Thomas; Guo-Jun Liu; Richard Banati
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-19       Impact factor: 6.200

Review 10.  Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.

Authors:  Valentina Berti; Cristina Polito; Gemma Lombardi; Camilla Ferrari; Sandro Sorbi; Alberto Pupi
Journal:  Neurol Sci       Date:  2016-01-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.